510(k) Report

510(k) · Cleared

Cleared

Fastpack Control Kit

K123725510(k) TraditionalCleared Mar 8, 201394-day reviewClass I21 CFR 862.1660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Qualigen, Inc. · JJY Multi-Analyte Controls, All Kinds (Assayed)

Cleared on Mar 8, 2013 as substantially equivalent to K960824 (Medical Analysis Systems, Inc., 1996) and 2 other predicates after a 94-day review. Its family tree reaches back 2 generations to 1994.

Decided
Mar 8, 2013
Review
94 days
Class
Class I
Product code
JJY
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K942566 (1994). 4 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2000: 1 other ancestor1996: 1 other ancestorK942566 · Imx Ultrasensistive HTSH II · Abbott Laboratories · 1994K052301 · Fastpack TSH Immunoassay · Qualigen, Inc. · 2006 · recalled199019952000200520102015
Other ancestors, by generation 1 generation back: 2 other ancestors K052301 · Fastpack TSH Immunoassay · Qualigen, Inc. · 2006 · recalledK942566 · Imx Ultrasensistive HTSH II · Abbott Laboratories · 19940
  1. Root · 2 generations backK942566 Imx Ultrasensistive HTSH IIAbbott Laboratories · 1994
  2. 1 generation backK052301 Fastpack TSH ImmunoassayQualigen, Inc. · 2006 · Recalled
  3. This deviceK123725 Fastpack Control KitQualigen, Inc. · 2013
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K942566Imx Ultrasensistive HTSH IIAbbott Laboratories1994—
−1K052301Fastpack TSH ImmunoassayQualigen, Inc.20061
0 (this device)K123725Fastpack Control KitQualigen, Inc.2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
200010
FIG. 1 — Lineage of K123725, 1994–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JJY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K960824Immunology Control
Summary page 2
…h 8, 2013 Devices to Which Substantial Equivalence is Claimed Immunology Control (containing FT4, testosterone, and hCG) Medical Analysis Systems, Camarillo, California K960824 FastPack®& Controls (containing PSA) Qualigen, Inc. Carlsbad, California K003095 FastPack®)TSH Controls Qualigen, Inc. Carlsbad…
Medical Analysis Systems, Inc.1996—
*K003095Fastpack Control
Summary page 2
…(containing FT4, testosterone, and hCG) Medical Analysis Systems, Camarillo, California K960824 FastPack®& Controls (containing PSA) Qualigen, Inc. Carlsbad, California K003095 FastPack®)TSH Controls Qualigen, Inc. Carlsbad, California K052301 Device Description FastPack® Control Kit is prepared in a…
Qualigen, Inc.2000—
*K052301Fastpack TSH Immunoassay
Summary page 2
…marillo, California K960824 FastPack®& Controls (containing PSA) Qualigen, Inc. Carlsbad, California K003095 FastPack®)TSH Controls Qualigen, Inc. Carlsbad, California K052301 Device Description FastPack® Control Kit is prepared in a synthetic matrix containing chemicals, preservatives, and stabilizer…
Qualigen, Inc.20061

Also cleared against K960824: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 2 companies; a new generation was cleared every 11.4 years on median.
  • 1 of the 4 ancestors has a recall of any class.
  • 2 other devices also cite its predicate K960824.

How does its category compare?

All JJY devices

JJY Multi-Analyte Controls, All Kinds (Assayed): FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · JJY

3in 2017

2007: 112008: 72009: 82010: 102011: 142012: 132013: 162014: 102015: 42016: 12017: 3
2007high 16 (2013) · low 0 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JJY

78in 2017

2007: 49 days median2008: 54 days median2009: 80 days median2010: 109 days median2011: 120 days median2012: 40 days median2013: 82 days median2014: 49 days median2015: 153 days median2017: 78 days median
2007high 153 (2015) · low 40 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JJY

2in 2025

2007: 52009: 22010: 62011: 12012: 32013: 22014: 22015: 12016: 32017: 42018: 32019: 42020: 62022: 32023: 32025: 22026 (partial year): 1
2007high 6 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JJY

13in 2025

2007: 22008: 12009: 32010: 32011: 62012: 202013: 52014: 42015: 42016: 132017: 122018: 72019: 12020: 72021: 12023: 42024: 12025: 13
2007high 20 (2012) · low 0 (2022)2025

MAUDE reports naming product code JJY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007114952
200875401
200988023
20101010963
20111412016
20121340320
2013168225
2014104924
2015415314
20161—313
2017378412
20180—37
20190—41
20200—67
20210—01
20220—30
20230—34
20240—01
20250—213
20260—1—

What is it indicated for?

The FastPack® Control Kit is an assayed quality control for the verification of the accuracy and precision of the FastPack® and FastPack® IP Systems when used for the quantitative determination of the analytes listed in the package insert. The following analytes are included in the package insert:

- Free Thyroxine (FT4)

- Human Chorionic Gonadotropin (hCG)

- Testosterone

- Total Prostate Specific Antigen (tPSA)

- Thyroid Stimulating Hormone (TSH)

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K123725: Fastpack Control Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K123725

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026